Smooth colibri tip used to grasp and subsequently retract the capsule during nucleus delivery. Serrated handle with polished finish.
Tennant straight tying forceps, 6.0 mm tying platforms, with pin, extra delicate smooth jaws.
O'Gawa-Castroviejo tying forceps, straight shafts, 6 mm tying platforms, wide handle.
Hatsis tying forceps, titanium, long thin tying platforms.
Medicine Products:(Date:1/8/2009)... Allscripts-Misys Health...are Solutions, Inc. (Allscripts or,the Company), ...e and six,months ended November 30, 2008. , ...1005/ALLSCRIPTSLOGO-b ) , The Company,s res...0, 2008,include results from legacy Allscripts fo...
(Date:1/8/2009).... 8 A new educational W...dance on drugs, biological products and medical de...Quality,s Centers for Education and Research on Th...of more than a dozen leading research centers nati...formation Network ( CHAIN ) http://www.chainonlin...
(Date:1/8/2009)...n. 8 Heska Corporation (... , , , What: Heska Corporation Invites ...Year-End 2008 Earnings Conference Call on the Web,.... (MST], Where: www.heska.com (click on t...ll link on the front page of this website)., ...
(Date:1/8/2009)...st Missile Strikes , , NEW YORK, Jan. 8 /PRNew...C) and the Jewish Federations of North America tod...itarian and social needs in southern Israel, part ...darity with Israelis during the current conflict w...f the Gaza Strip. , , The funds will enhance p...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2...lonoscopy is the gold standard for detecting colon...s it is a very invasive test.// Recently, a fecal ...ooks for blood hidden in the stool. However, the t...w test looks for DNA mutations in the stool. Resea...
...archers have discovered the Polymeal -- a combined...ardiovascular disease // by more than 75 percent. ...fruits and vegetables, almonds and garlic, which a...imes a week only of fish). Researchers figured out...
...le with epilepsy might benefit from the implantati...rchers arrived at the conclusion // after studying...a significant occurrence of interrupted heart rhyt...heart rhythms during seizures might be responsible...
...w study shows a diet rich in omega-3 and omega-6 f...fen in breast cancer // patients. Researchers say ...et rich in omega-3 fatty acids. For the study the ...The first received a diet rich in omega-6 fatty ac...
Other Medicine News:(Date:1/7/2009)...ent Based On Osteotech,s Proprietary Human Collage... FDA Filing Anticipated in Third Quarter 2009 , ... -- Osteotech, Inc. (Nasdaq: OSTE ), a leader ...enerative healing, announced today that it has ini...M) BioRegeneration Matrix. The first five patients...
(Date:1/6/2009)... from prior U.S., U.K. and China Trials , , SAN...c. (VTI), a development stage company targeting li...s begun for a randomized, controlled, multi-center...corporeal Liver Assist Device (ELAD) as a treatmen...r three protocols. The study is open for enrollmen...
(Date:1/6/2009)...re/ -- The Michael J. Fox Foundation awarded a tot... teams for pre-clinical research on potential new ...ding was awarded under the Foundation,s Therapeut...aunched in 2006, supports and bolsters industry-fo...rt of MJFF,s focus on ,de-risking, preclinical P...
(Date:1/6/2009)...ire/ -- Pacira Pharmaceuticals, Inc., an,acute ca...ay that enrollment,has been completed in two pivo...y and efficacy of a single intraoperative administ...nged postoperative analgesia. , Results fro...e,arthroplasty (TKA) are expected to provide the ...
Breaking Medicine Technology:Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3FDA and Pharsight Continue to Collaborate Under CRADA 8019 1FDA and Pharsight Continue to Collaborate Under CRADA 8019 2FDA and Pharsight Continue to Collaborate Under CRADA 8019 3FDA and Pharsight Continue to Collaborate Under CRADA 8019 4TriWest Contributes 2420 000 to Utah National Guard 8016 1TriWest Contributes 2420 000 to Utah National Guard 8016 2XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 an International Scientific Conference 1034 1XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 an International Scientific Conference 1034 2XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 an International Scientific Conference 1034 3Clemson researcher studies carbon fibers for nuclear reactor safety 2126 1Clemson researcher studies carbon fibers for nuclear reactor safety 2126 2... SEATTLE, June 04, 2007 /PRNewswire-FirstCall/ --...indings were presented from a,Phase 1b clinical tr...eukemia (B-CLL) at the American Society of Clinica...ncluded intravenous,administration of higher doses...ound that atacicept was well-tolerated and biologi...
... HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - A...nnounced that the,Company presented a "meta-analys... Fampridine-SR in multiple sclerosis during a,post... and Research,in MS (ACTRIMS) Meeting in Washingto...lidation of Consistent Improvement in Walking,Spee...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4